DK1389116T3 - Kathartisk præparat - Google Patents

Kathartisk præparat

Info

Publication number: DK1389116T3
Authority: DK; Denmark
Prior art keywords: cathartic preparation; cathartic; preparation
Prior art date: 2001-05-18

Application number

DK02771715T

Other languages

English (en)

Inventor

Ryuji Ueno

Original Assignee

Sucampo Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-18

Filing date

2002-05-17

Publication date

2008-06-23

2002-05-17 Application filed by Sucampo Ag filed Critical Sucampo Ag

2008-06-23 Application granted granted Critical

2008-06-23 Publication of DK1389116T3 publication Critical patent/DK1389116T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
- A61K31/025—Halogenated hydrocarbons carbocyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK02771715T 2001-05-18 2002-05-17 Kathartisk præparat DK1389116T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29163501P	2001-05-18	2001-05-18
PCT/JP2002/004768 WO2002094274A1 (en)	2001-05-18	2002-05-17	Cathartic composition

Publications (1)

Publication Number	Publication Date
DK1389116T3 true DK1389116T3 (da)	2008-06-23

Family

ID=23121127

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02771715T DK1389116T3 (da)	2001-05-18	2002-05-17	Kathartisk præparat

Country Status (18)

Country	Link
US (2)	US6956056B2 (da)
EP (1)	EP1389116B1 (da)
JP (1)	JP4597481B2 (da)
KR (1)	KR100867295B1 (da)
CN (1)	CN1273140C (da)
AR (3)	AR035242A1 (da)
AT (1)	ATE387204T1 (da)
AU (1)	AU2002307725B2 (da)
BR (1)	BR0209863A (da)
CA (1)	CA2445651C (da)
DE (1)	DE60225266T2 (da)
DK (1)	DK1389116T3 (da)
ES (1)	ES2301681T3 (da)
MX (1)	MXPA03010510A (da)
NZ (1)	NZ529406A (da)
PT (1)	PT1389116E (da)
TW (2)	TWI320711B (da)
WO (1)	WO2002094274A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI302100B (en) *	2001-05-02	2008-10-21	Sucampo Ag	Composition for treating drug-induced constipation
TWI331920B (en)	2001-11-14	2010-10-21	Sucampo Ag	Unit dosage form for relieving or treating constipation in human patients
WO2004037268A1 (en) *	2002-10-23	2004-05-06	Sucampo Ag	Prostaglandin compounds for the treatment of obesity
BRPI0317740B8 (pt) *	2002-12-27	2021-05-25	Sucampo Ag	uso do composto 13,14-diidro-15-ceto-16,16-diflúorprostaglandina e1
US7049319B2 (en)	2003-09-23	2006-05-23	Semaan Abboud	Colon cleansing composition and method
TWI387454B (zh)	2004-09-02	2013-03-01	Sucampo Ag	治療胃腸道疾病之方法及組成物
US20070071793A1 (en) *	2005-09-23	2007-03-29	Leon Clark	Cure for prostate enlargement frequency of urination and cancer
KR101437302B1 (ko) *	2006-02-07	2014-09-02	가부시키가이샤 아루떼꾸 우에노	프로스타글란딘 유도체의 제조 방법
CN102050808B (zh) *	2009-11-02	2014-03-12	上海天伟生物制药有限公司	一种前列腺素中间体的制备方法
JP6499591B2 (ja) *	2013-02-25	2019-04-10	シナジーファーマシューティカルズインコーポレイテッド	結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
WO2014159679A1 (en)	2013-03-12	2014-10-02	The United States Of America, As Represented By The Secretary, Department Of Health & Human Services	Methods for using lubiprostone to absorb fluid from the subretinal space
US11534404B2 (en)	2016-10-06	2022-12-27	Sucampo Ag	Multilayer beads for pharmaceutical use
US10457623B1 (en) *	2018-07-13	2019-10-29	Chirogate International Inc.	Process for the preparation of Lubiprostone and intermediates thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1396207A (en) *	1972-04-27	1975-06-04	Upjohn Co	Prostaglandin intermediates and the preparation thereof
US3969376A (en) *	1973-07-20	1976-07-13	The Upjohn Company	13,14-Dihydro-16-fluoro prostaglandin E1 analogs
JPS5037770A (da) *	1973-07-20	1975-04-08
US3969379A (en) *	1975-02-21	1976-07-13	The Upjohn Company	13,14-Dihydro-16-fluoro prostaglandin A1 analogs
US3969381A (en) *	1975-02-21	1976-07-13	The Upjohn Company	13,14-Dihydro-16-fluoro prostaglandin B1 analogs
GB8305697D0 (en) *	1983-03-02	1983-04-07	Erba Farmitalia	Pharmaceutical compositions
EP0153858A3 (en) *	1984-02-29	1985-12-11	The Upjohn Company	The therapeutic use of prostaglandins
GB2210556B (en) *	1987-10-02	1991-07-17	Ueno Seiyaku Oyo Kenkyujo Kk	The use of 15-keto-16-halo-prostaglandins in cathartic compositions
JPH0681728B2 (ja) *	1987-10-02	1994-10-19	株式会社上野製薬応用研究所	下剤
JP2579193B2 (ja)	1988-07-19	1997-02-05	小野薬品工業株式会社	１６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
ATE174221T1 (de)	1990-05-01	1998-12-15	R Tech Ueno Ltd	Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
CA2046069C (en) *	1990-07-10	2002-04-09	Ryuji Ueno	Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DE69213057T2 (de) *	1991-03-14	1997-01-09	Ueno Seiyaku Oyo Kenkyujo Kk	Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen
JP3183615B2 (ja) *	1994-06-03	2001-07-09	株式会社アールテック・ウエノ	肝・胆道系疾患処置剤
ES2182088T3 (es) *	1996-06-10	2003-03-01	Sucampo Ag	Antagonista de la endotelina.
JP4786866B2 (ja) *	2001-08-31	2011-10-05	スキャンポ・アーゲー	クロライドチャンネルオープナーとしてのプロスタグランジンアナログ

2002
- 2002-05-17 CN CNB028101847A patent/CN1273140C/zh not_active Expired - Lifetime
- 2002-05-17 AR ARP020101832A patent/AR035242A1/es not_active Application Discontinuation
- 2002-05-17 JP JP2002590991A patent/JP4597481B2/ja not_active Expired - Lifetime
- 2002-05-17 CA CA2445651A patent/CA2445651C/en not_active Expired - Lifetime
- 2002-05-17 AT AT02771715T patent/ATE387204T1/de active
- 2002-05-17 NZ NZ529406A patent/NZ529406A/en not_active IP Right Cessation
- 2002-05-17 ES ES02771715T patent/ES2301681T3/es not_active Expired - Lifetime
- 2002-05-17 WO PCT/JP2002/004768 patent/WO2002094274A1/en active IP Right Grant
- 2002-05-17 EP EP02771715A patent/EP1389116B1/en not_active Expired - Lifetime
- 2002-05-17 TW TW091110333A patent/TWI320711B/zh not_active IP Right Cessation
- 2002-05-17 MX MXPA03010510A patent/MXPA03010510A/es active IP Right Grant
- 2002-05-17 AU AU2002307725A patent/AU2002307725B2/en not_active Expired
- 2002-05-17 PT PT02771715T patent/PT1389116E/pt unknown
- 2002-05-17 BR BR0209863-6A patent/BR0209863A/pt not_active Application Discontinuation
- 2002-05-17 TW TW098122730A patent/TWI324589B/zh not_active IP Right Cessation
- 2002-05-17 DK DK02771715T patent/DK1389116T3/da active
- 2002-05-17 KR KR1020037014860A patent/KR100867295B1/ko active IP Right Grant
- 2002-05-17 DE DE60225266T patent/DE60225266T2/de not_active Expired - Lifetime
- 2002-05-20 US US10/147,980 patent/US6956056B2/en not_active Expired - Lifetime
2005
- 2005-07-28 US US11/190,842 patent/US7459583B2/en not_active Expired - Lifetime
2014
- 2014-12-12 AR ARP140104644A patent/AR098744A2/es not_active Application Discontinuation
2017
- 2017-11-08 AR ARP170103100A patent/AR110149A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
NZ529406A (en)	2005-09-30
US20050261375A1 (en)	2005-11-24
ES2301681T3 (es)	2008-07-01
PT1389116E (pt)	2008-04-11
KR100867295B1 (ko)	2008-11-06
AR098744A2 (es)	2016-06-08
ATE387204T1 (de)	2008-03-15
KR20040020055A (ko)	2004-03-06
US20030022933A1 (en)	2003-01-30
WO2002094274A1 (en)	2002-11-28
CA2445651A1 (en)	2002-11-28
TWI320711B (en)	2010-02-21
BR0209863A (pt)	2004-06-08
TW200944210A (en)	2009-11-01
DE60225266D1 (de)	2008-04-10
MXPA03010510A (es)	2004-03-02
EP1389116A1 (en)	2004-02-18
JP2004529960A (ja)	2004-09-30
CA2445651C (en)	2011-08-09
US6956056B2 (en)	2005-10-18
AU2002307725B2 (en)	2008-07-10
AR110149A2 (es)	2019-02-27
CN1273140C (zh)	2006-09-06
US7459583B2 (en)	2008-12-02
CN1509176A (zh)	2004-06-30
AR035242A1 (es)	2004-05-05
JP4597481B2 (ja)	2010-12-15
TWI324589B (en)	2010-05-11
EP1389116B1 (en)	2008-02-27
DE60225266T2 (de)	2009-03-19

Publication	Publication Date	Title
DK1857105T3 (da)	2010-09-20	Kathartisk præparat
IS7016A (is)	2003-11-05	Ný 4-anilínókínólín-3-karboxamíð
ATE524462T1 (de)	2011-09-15	C5-modifizierte indazolylpyrrolotriazine
CY2014009I1 (el)	2015-12-09	Παρασιτοκτονα σκευασματα
DE50103741D1 (de)	2004-10-28	Welle-Nabe-Verbindung
ATE335486T1 (de)	2006-09-15	Hydrazono-malonitrile
DK1389116T3 (da)	2008-06-23	Kathartisk præparat
DE50203984D1 (de)	2005-09-22	Kugelgelenk
ATE355059T1 (de)	2006-03-15	Isoxazolopyridinone
DE50201862D1 (de)	2005-01-27	Messwandler
DE50203093D1 (de)	2005-06-16	Losradlager
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
DE50202088D1 (de)	2005-03-03	Garmodulsystem
ATA13992002A (de)	2003-10-15	Schlackengranulierungsanlage
DE50108381D1 (de)	2006-01-19	Synchronisierschaltungsanordnung
DE10295006D2 (de)	2004-10-07	Bauwerksabdichtung
AT500276B1 (de)	2006-06-15	Radschwenksystem
ATA7462001A (de)	2002-01-15	Radspannwerk
DE10196706D2 (de)	2004-07-01	Nagelfeile
DE10142202B8 (de)	2008-11-20	Hochvakuumbedampfungsanlage
DE10295832D2 (de)	2004-10-28	Dioxathianone
ATA6162001A (de)	2002-11-15	Schneekette
BRMU8103332U2 (pt)	2017-01-31	terço fácil
SE0101122D0 (sv)	2001-03-28	Novel use
SE0101037D0 (sv)	2001-03-23	Novel use